These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 11799348

  • 21. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
    Małyszczak K, Inglot M, Pawłowski T, Czarnecki M, Rymer W, Andrzej K.
    Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
    [Abstract] [Full Text] [Related]

  • 22. Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status.
    Van Gool AR, Verkerk R, Fekkes D, Bannink M, Sleijfer S, Kruit WH, van der Holt B, Scharpé S, Eggermont AM, Stoter G, Hengeveld MW.
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):597-602. PubMed ID: 18950381
    [Abstract] [Full Text] [Related]

  • 23. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
    Russo S, Kema IP, Haagsma EB, Boon JC, Willemse PH, den Boer JA, de Vries EG, Korf J.
    Psychosom Med; 2005 Oct; 67(5):773-7. PubMed ID: 16204437
    [Abstract] [Full Text] [Related]

  • 24. Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C.
    Małyszczak K, Inglot M, Frydecka D, Hadryś T, Pawłowski T.
    Adv Clin Exp Med; 2019 Sep; 28(9):1217-1222. PubMed ID: 30811903
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
    Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr 29; 35(3):702-21. PubMed ID: 21185346
    [Abstract] [Full Text] [Related]

  • 30. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.
    Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R.
    Mol Psychiatry; 2002 Apr 29; 7(5):468-73. PubMed ID: 12082564
    [Abstract] [Full Text] [Related]

  • 31. Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): results from a prospective study.
    Lieb K, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Janssen G, Schaefer M.
    Eur Psychiatry; 2006 Apr 29; 21(3):204-10. PubMed ID: 16632167
    [Abstract] [Full Text] [Related]

  • 32. Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation.
    Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpé S.
    Life Sci; 2002 Sep 06; 71(16):1837-48. PubMed ID: 12175700
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy.
    Kraus MR, Schäfer A, Faller H, Csef H, Scheurlen M.
    J Clin Psychiatry; 2003 Jun 06; 64(6):708-14. PubMed ID: 12823087
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Induction of indoleamine 2,3-dioxygenase in vivo by IFN-con1.
    Sweeten TL, Ferris M, McDougle CJ, Kwo P, Taylor MW.
    J Interferon Cytokine Res; 2001 Aug 06; 21(8):631-3. PubMed ID: 11559441
    [Abstract] [Full Text] [Related]

  • 39. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.
    Wichers M, Maes M.
    Int J Neuropsychopharmacol; 2002 Dec 06; 5(4):375-88. PubMed ID: 12466036
    [Abstract] [Full Text] [Related]

  • 40. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy.
    Maes M, Capuron L, Ravaud A, Gualde N, Bosmans E, Egyed B, Dantzer R, Neveu PJ.
    Neuropsychopharmacology; 2001 Feb 06; 24(2):130-40. PubMed ID: 11120395
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.